
Lonza
company0.0Global Dominance: 0.00%
Lonza is a leading Swiss pharmaceutical and biotechnology company with a strong focus on custom manufacturing of biologics and other pharmaceutical products. Known for its extensive expertise in the life sciences sector, Lonza has built a reputation for quality and innovation, providing essential services to pharmaceutical companies worldwide.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Lonza is a Swiss company that is facing increased competition from Samsung Biologics in the peptide manufacturing sector.
Druck steigt auch auf Lonza und BachemNeue Zürcher Zeitung·
Switzerland· 2026-07-20



